Pfizer Inc.

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug

COVID-19 vaccine makers’ shares slump, but there’s upside as other products hit the market

Pfizer to invest more than US$2.5-billion to expand European manufacturing

Pfizer raises full-year sales estimates for its COVID-19 vaccine by $2-billion

European Medicines Agency recommends adding heavy periods to side effects of mRNA COVID-19 vaccines

U.S. government to test Pfizer’s Paxlovid for long COVID

Coronavirus Update: Children’s hospitals report major upswing in patients seeking help for viruses

Saskatchewan rolling out Pfizer-BioNTech’s COVID-19 shot for kids under age of four

Pfizer says COVID-19 vaccine will cost US$110-$130 per dose once government stops buying

Pfizer, BioNTech find updated COVID-19 booster protects against Omicron in trial

FDA authorizes revised COVID-19 booster shots for children 5-11

COVID-19 rebound after Pfizer treatment likely due to robust immune response, study finds

Japan authorizes Pfizer COVID-19 vaccine for use with young children

A Chinese mRNA COVID-19 vaccine gains its first approval - in Indonesia

Health Canada approves Pfizer COVID-19 vaccine for kids under five

EU drug regulator backs Omicron-adapted COVID-19 shots

Canada to announce approval of Moderna vaccine for Omicron variant on Thursday, CBC reports

U.S. FDA authorizes updated COVID-19 booster shots targeting Omicron subvariants

Europe to receive Omicron COVID-19 vaccines within days of approval, says member of parliament